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Abstract: Several non-permanent polycations possessing substantial buffering 
capacity below physiological pH, such as lipopolyamines and polyethylenimines, are 
efficient transfection agents per se, i.e. without the addition of lysosomotropic bases, 
or cell targeting or membrane disruption agents. These vectors have been shown to 
deliver genes as well as oligonucleotides both in vitro and in vivo. Our hypothesis is 
that their efficiency relies on extensive endosome swelling and rupture that provides 
an escape mechanism for the polycatiordDNA particles. 
Introduction. 
Gene transfer is the weak link of gene therapy and DNA is a pro-drug rather 
than the therapeutic effector molecule itself. The cascade of events leading to the 
synthesis of a large number of therapeutic protein molecules from a single gene 
begins in the nucleus. Therefore vector systems are required to carry the exogeneous 
DNA through the plasma and nuclear membranes. Most often, recombinant viral 
vectors are used for this task ( l ) ,  since viruses have evolved sophisticated break-in 
ways (2) that can now be exploited. These include efficient cell membrane rupture 
mechanisms and nuclear targeting. Membrane rupture can occur either directly at the 
cell surface or after endocytosis. In any case the viral fusogenic protein becomes 
'informed' of the cell proximity and undergoes a major conformational change 
induced either by binding to a cell surface receptor or by the acidic nature of the 
endosomal compartment. Chemists examining such complex molecular sequences 
may well be daunted. Yet synthetic non-viral gene transfer systems, however basic, 
will be of great potential to the gene therapy field just as soon as they show sufficient 
in vivo transfection capacities. We insist on the term sufficient, - the same ad-jective is 
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apparently used to describe the Rolls-Royce engine in the technical notice 
accompanying the car!- as it suggests an adequate performance. However, as 
emphasised by the recent British and American attempts to apply gene therapy to 
cystic fibrosis or melanoma patients, we know that this criterion is far from being 
satisfied (1 b). 
Chemistry is not constrained by the need for replication characteristic of a 
biological system and can therefore explore and exploit a much wider spectrum of 
candidate molecules for a given task. With some imaginative leads and a great deal of 
'evolutionary' trial and error, two classes of synthetic vectors have been developed 
over the last decade. These compounds, whether lipids (3) or polymers (4), are all 
cationic like their classical predecessors used for in vitro transfection (calcium 
phosphate, DEAE-dextran). On complexing with DNA they cause several plasmid 
molecules to condense together into sub-micrometric particles. Oligonucleotides 
share many features with genes, being rather fragile polyanionic molecules with 
intracellular targets. Yet their much smaller size leads to smaller complexes and 
allows molecules to diffuse in the cytoplasm. Thus oligonucleotides delivery looks 
simpler and results achieved with genes, which is the main topic of this discussion, 
will u ,fortiori apply to oligonucleotides. 
In vitro transfection with cationic lipids (5). 
When a cationic lipid is used at an excess ratio of cationic charges to nucleic acid 
phosphates, the resulting nucleo-lipid particles will fix to the cell surface. Indeed, in 
vitro, electrostatic interactions between the positively charged DNNlipid complexes 
and anionic heparan mlfate proteoglycans of the cell membranes are enhanced hy 
increasing the overall charge of the complexes, which is in turn achieved hy 
increasing the ratio of lipid to DNA. This interaction between the particle and the cell 
membrane is spontaneously followed by endocytosis. Cationic lipids give variable 
transfection efficiencies that depend both on the chemical structure of the vector and 
on the cell type. Even so, irrespective of the cell type, the lipopolyamines constitute 
one of most efficient vector classes ( 3 ,  6). This general efficiency is an intrisic 
property of the charged headgroup, and the addition of neither fusogenic lipids or of 
nuclear localisation signals can increase it,  suggesting that the polyamine headgroup 
may in itself carry these multifunctional properties. Moreover, when the 
potentiometric protonation states of thc amines were measured, it was found that at 
physiological pH only three of the four nitrogens in the spermine head were cationic 
(Figure 1). The pKa of the last amine is 5.5, half way between the extracellular and 
intralysosomial pH values, a clue to a possible buffering property that could well be 
exploited, and a point we shall return to later. 
In vitro transfection with cationic polymers. 
Compared to the lipopolyamines, most members of the other class of cationic 
molecules - the cationic polymers such as poly-L-lysine - are relatively inefficient 
unless conjugated to a ligand that can provoke endocytosis when bound to its cell 
surface located receptor (4). Even then transfection levels only reach those obtained 
with with lipopolyamines when the polymer is conjugated to adenoviral particles that 
lyse endosomes (9). However, the use of the non-specific adenovirus components 
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Figure 1. Chemical structure of the lipopolyamine Transfectam Stl  ; at neutral 
counteracts the cell targeting function obtained with the ligand. Recently, an 
exemplary class member of the cationic polymers has emerged with the description 
of the transfection properties of the polyamidoamine dendrimers ( 10). These 
quasispherical macromolecules bear a large number of amine groups on their surface 
and again, as for the lipopolyamines, not all of these amines are protonated at 
physiological pH. 
So by observing two completely different cationic vectors, a lipid and a 
polymer, we are led to the same question: whether there is a causal relation between 
the overall buffering capacity of a vector under physiological conditions and its 
transfection possibilities. Accordingly, a number of macromolecular compounds 
bearing high amine group densities were considered for synthesis. Such cationic 
compounds would still be able to compact DNA, but owing to the repulsion predicted 
between like charges at close proximity, they would not be fully protonated at 
physiological pH. 
As it turned out there was no need to start synthesizing candidates, as the ideal 
molecule was already available. In the commercially available polymer 
polyethyenimine (PEI, Figure 2) one in every three atoms is an amine group and the 
overall protonation level increases from 20 to 45%J between pH 7 and 5. Moreover, 
the compound was described over 50 years ago and its innocuity demonstrated by its 
intensive and various uses: in water purification, ore extraction and in shampoos. We 
tested the transfection efficiency of this polymer, comparing it to lipopolyamines on a 
large variety of cell lines and primary cultures (12). The results are most promising, 
showing efficiencies at least as high as the best currently available synthetic vectors 
(Figure 3) indicating an entirely new function for this simple molecule. 
Gene transfer in vivo. 
Results obtained in vivo are quite encouraging too. The main limitation of 
current non-viral gene transfer methods is their low efficiencies in vivo. This is 
particularly marked for the cationic polymers like poly-L-lysine. As to the cationic 
lipids, such as Lipofectin, DOTAP, DC-Chol and Transfectam, which have been on 
the market for eight years or so, only recently have reports appeared showing their 
potential use for in vivo gene therapy situations (lb). Transfectam can provide 
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Figure 2. Chemical structure of polyethyleneimine at neutral pH . 
Figure 3.  Expression of 13-galactosidase following transfection (2 pg CMV-Pgal) with 
PEI in the murine 3T3 fibroblast cell line. 
reasonable levels ot transfection when used alone, without the adjonction of a neutral 
lipid, in the chick embryo (13) and in the mouse embryo transfected through 
introduction of DNA complexed with lipid into the maternal blood supply (14). In 
the newborn mouse brain we found ( 16) high levels of transfection using Transfectam 
at a low charge ratio with respect to the DNA and compensating the low overall 
amount of lipid (17) by the addition of a two-fold molar excess of the zwitterionic 
lipid, dioleoyl phosphatidylethanolamine (DOPE). Other authors have also reported 
that mixtures of  cationic lipids and DOPE used at low overall charge ratios can 
deliver genes in vivo, either with Lipofectin (which is commercialised as a mixture of 
a cationic lipid and DOPE, see for example ref 15) or with Transfectam (18). 
In the newborn mouse brain PEI/ DNA complexes have been shown to provide levels 
of transfection equal to those found in vitrci for the same amount of DNA applied to 
primary neuronal cultures ( 1  1, Figure 4). Moreover, in more compact tissues such as 
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Figure 4. Spatial distribution of 13 galactosidase expression in the newborn mouse 
brain after transfection of lpg CMV-Bgal complexed with PEI (volume 2p1) into the 
striatum. A: low power overall view of the clarified brain, B: higher power view of 
the cerebral hemispheres, C and D: higher power views of the olfactory bulbs, E: 
higher power view of neurons labelled in the cerebral cortex. Photo: B. Abdallah, C. 
Benoist, MNHN, Paris. 
the adult mammalian brain where cationic lipids provide either very low levels of 
transfection (16) or are actually worse than naked DNA, PEI also improves delivery. 
It can be complexed with DNA in various volumes (1 to $1) and used to transfect 
either delimited structures or larger regions of the adult mouse brain (19). Use of 
double immunostaining with antibodies against cell specific markers and transgene 
products show that both neurons and glia can be transduced by PEI transfection in 
viva Acute toxicity seems to be low, as no mortality nor necrosis at the site of 
injection has been observed in injected animals. A final point of interest is that when 
transfecting neuronal cells in culture with genes as well as with oligonucleotides, not 
only could gene expression and antisense effects be demonstrated, but also no 
interference with membrane excitability was seen (20). Thus, PEI appears to be an 
ideal vector for gene transfer into the brain in vivo and future studies will show if can 
be adapted to other tissues. 
Gene transfer mechanism (5). 
The sequence of events that we hypothesize to account for the remarkable 
transfection properties of PEI are summarized in Figure 5. The polycation/DNA 
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Figure 5. The proton sponge hypothesis: H+ and C1- entry into the endosome leads to 
osmotic swelling and finally to endosome rupture. 
complexes enter the cell by spontaneous endocytosis. A complex wholly covered in 
positive charges interacting with the cell membrane will produce a high local 
concentration of PEI in the endosome. During the intracellular trafficking the 
buffering capacity of the PEI will not only tend to inhibit the action of the lysosomal 
nucleases that have an acid optimal pH, hut will also alter the osmolarity of the 
vesicle. The accumulation of protons brought in by the endosomal ATPase is coupled 
to an influx of chloride anions (21). In the presence of PEI there will be an large 
increase in the ionic concentration within the endosome resulting in osmotic swelling 
of the endosome. Moreover PEI protonation will also expand its polymeric network 
by internal charge repulsion (22). With the two phenomena occuring simultaneously 
it is likely that endosoinal life expectancy is sorely reduced! Taking into account the 
protonation profile of PEI we can expect that about a third of the nitrogen atoms in 
the molecule participate in the swelling action, making the molecule a virtual proton 
sponge. For gene therapy the interesting aspect of this mechanism (which is 
somewhat 'primitive' compared to the mechanisms developed by viruses) is that it 
will lead to enhanced gene transfer, as the DNA introduced with the PEI will be 
rapidly liberated from the damaging endosomal environment. Thus, this molecule 
constitutes, per se, a promising vector for gene therapy and an ideal structural base 
for constructing more sophisticated vectors that could include supplementary 
functions such as cell-specific targeting ligands. 
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